TTY Biopharm : To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.

Close

Today's Information

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO	2	Date of announcement	2022/05/26	Time of announcement	17:03:34
Subject	To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.
Date of events	2022/05/26	To which item it meets	paragraph 53
Statement	1.Date of occurrence of the event:2022/05/26 2.Company name:TTY Biopharm Company 3.Relationship to the Company (please enter "head office" or "subsidiaries"):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence: The Company received milestone for USD 500,000 from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug, "Octreotide LAR" due to the Company has completed pilot clinical trial. 6.Countermeasures:To announce major information 7.Any other matters that need to be specified:None.